PHARMANUTRA SPA (PHN.MI) Stock Fundamental Analysis
Europe - BIT:PHN - IT0005274094 - Common Stock
39.5 EUR
-0.7 (-1.74%)
PHN gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 13 industry peers in the Personal Care Products industry. PHN scores excellent points on both the profitability and health parts. This is a solid base for a good stock. PHN is not overvalued while it is showing excellent growth. This is an interesting combination. These ratings would make PHN suitable for growth and quality investing!
1. Profitability
1.1 Basic Checks
PHN had positive earnings in the past year.
In the past year PHN had a positive cash flow from operations.
PHN had positive earnings in each of the past 5 years.
In the past 5 years PHN always reported a positive cash flow from operatings.
1.2 Ratios
PHN has a Return On Assets of 20.41%. This is amongst the best in the industry. PHN outperforms 100.00% of its industry peers.
PHN's Return On Equity of 38.54% is amongst the best of the industry. PHN outperforms 100.00% of its industry peers.
The Return On Invested Capital of PHN (26.24%) is better than 100.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for PHN is above the industry average of 12.52%.
The 3 year average ROIC (17.21%) for PHN is below the current ROIC(26.24%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 20.41% | ||
| ROE | 38.54% | ||
| ROIC | 26.24% |
ROA(3y)13.53%
ROA(5y)17.42%
ROE(3y)26.61%
ROE(5y)29.54%
ROIC(3y)17.21%
ROIC(5y)18.21%
1.3 Margins
PHN has a better Profit Margin (13.48%) than 76.92% of its industry peers.
In the last couple of years the Profit Margin of PHN has declined.
PHN has a better Operating Margin (21.87%) than 100.00% of its industry peers.
PHN's Operating Margin has been stable in the last couple of years.
With an excellent Gross Margin value of 97.04%, PHN belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
In the last couple of years the Gross Margin of PHN has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 21.87% | ||
| PM (TTM) | 13.48% | ||
| GM | 97.04% |
OM growth 3Y-4.84%
OM growth 5Y1.01%
PM growth 3Y-10.74%
PM growth 5Y-1.82%
GM growth 3Y-0.75%
GM growth 5Y-0.04%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), PHN is creating value.
The number of shares outstanding for PHN remains at a similar level compared to 1 year ago.
Compared to 5 years ago, PHN has less shares outstanding
PHN has a better debt/assets ratio than last year.
2.2 Solvency
PHN has an Altman-Z score of 8.03. This indicates that PHN is financially healthy and has little risk of bankruptcy at the moment.
PHN's Altman-Z score of 8.03 is amongst the best of the industry. PHN outperforms 100.00% of its industry peers.
PHN has a debt to FCF ratio of 2.70. This is a good value and a sign of high solvency as PHN would need 2.70 years to pay back of all of its debts.
PHN has a better Debt to FCF ratio (2.70) than 69.23% of its industry peers.
PHN has a Debt/Equity ratio of 0.28. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of PHN (0.28) is better than 61.54% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.28 | ||
| Debt/FCF | 2.7 | ||
| Altman-Z | 8.03 |
ROIC/WACC3.35
WACC7.84%
2.3 Liquidity
PHN has a Current Ratio of 2.06. This indicates that PHN is financially healthy and has no problem in meeting its short term obligations.
PHN has a better Current ratio (2.06) than 92.31% of its industry peers.
A Quick Ratio of 1.75 indicates that PHN should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.75, PHN belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.06 | ||
| Quick Ratio | 1.75 |
3. Growth
3.1 Past
PHN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 20.20%, which is quite impressive.
Measured over the past years, PHN shows a quite strong growth in Earnings Per Share. The EPS has been growing by 14.63% on average per year.
Looking at the last year, PHN shows a quite strong growth in Revenue. The Revenue has grown by 15.06% in the last year.
PHN shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 16.59% yearly.
EPS 1Y (TTM)20.2%
EPS 3Y6.71%
EPS 5Y14.63%
EPS Q2Q%3.36%
Revenue 1Y (TTM)15.06%
Revenue growth 3Y19.25%
Revenue growth 5Y16.59%
Sales Q2Q%10.35%
3.2 Future
Based on estimates for the next years, PHN will show a quite strong growth in Earnings Per Share. The EPS will grow by 14.27% on average per year.
PHN is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 12.23% yearly.
EPS Next Y13.36%
EPS Next 2Y15.1%
EPS Next 3Y14.27%
EPS Next 5YN/A
Revenue Next Year14.66%
Revenue Next 2Y13.77%
Revenue Next 3Y12.23%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 16.12, the valuation of PHN can be described as correct.
100.00% of the companies in the same industry are more expensive than PHN, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 27.32, PHN is valued a bit cheaper.
The Price/Forward Earnings ratio is 15.67, which indicates a correct valuation of PHN.
69.23% of the companies in the same industry are more expensive than PHN, based on the Price/Forward Earnings ratio.
PHN is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.89, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.12 | ||
| Fwd PE | 15.67 |
4.2 Price Multiples
61.54% of the companies in the same industry are more expensive than PHN, based on the Enterprise Value to EBITDA ratio.
PHN's Price/Free Cash Flow ratio is a bit more expensive when compared to the industry. PHN is more expensive than 76.92% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 46.68 | ||
| EV/EBITDA | 9.14 |
4.3 Compensation for Growth
PHN's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PHN has an outstanding profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as PHN's earnings are expected to grow with 14.27% in the coming years.
PEG (NY)1.21
PEG (5Y)1.1
EPS Next 2Y15.1%
EPS Next 3Y14.27%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 2.40%, PHN has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 2.63, PHN pays a bit more dividend than its industry peers.
PHN's Dividend Yield is comparable with the S&P500 average which is at 2.38.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.4% |
5.2 History
The dividend of PHN is nicely growing with an annual growth rate of 11.21%!
Dividend Growth(5Y)11.21%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
PHN pays out 40.63% of its income as dividend. This is a bit on the high side, but may be sustainable.
The dividend of PHN is growing, but earnings are growing more, so the dividend growth is sustainable.
DP40.63%
EPS Next 2Y15.1%
EPS Next 3Y14.27%
BIT:PHN (9/26/2025, 7:00:00 PM)
39.5
-0.7 (-1.74%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)
Earnings (Next)
Inst Owners15.44%
Inst Owner ChangeN/A
Ins Owners65.02%
Ins Owner ChangeN/A
Market Cap382.36M
Analysts83.33
Price Target80.58 (104%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.4% |
Yearly Dividend0.85
Dividend Growth(5Y)11.21%
DP40.63%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-3.66%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-2.66%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.58%
Revenue NY rev (3m)0.24%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.12 | ||
| Fwd PE | 15.67 | ||
| P/S | 2.18 | ||
| P/FCF | 46.68 | ||
| P/OCF | 31.02 | ||
| P/B | 6.24 | ||
| P/tB | 10.24 | ||
| EV/EBITDA | 9.14 |
EPS(TTM)2.45
EY6.2%
EPS(NY)2.52
Fwd EY6.38%
FCF(TTM)0.85
FCFY2.14%
OCF(TTM)1.27
OCFY3.22%
SpS18.09
BVpS6.33
TBVpS3.86
PEG (NY)1.21
PEG (5Y)1.1
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 20.41% | ||
| ROE | 38.54% | ||
| ROCE | 45.24% | ||
| ROIC | 26.24% | ||
| ROICexc | 32.19% | ||
| ROICexgc | 49.25% | ||
| OM | 21.87% | ||
| PM (TTM) | 13.48% | ||
| GM | 97.04% | ||
| FCFM | 4.68% |
ROA(3y)13.53%
ROA(5y)17.42%
ROE(3y)26.61%
ROE(5y)29.54%
ROIC(3y)17.21%
ROIC(5y)18.21%
ROICexc(3y)25.61%
ROICexc(5y)33.67%
ROICexgc(3y)43.23%
ROICexgc(5y)50.61%
ROCE(3y)29.76%
ROCE(5y)31.61%
ROICexcg growth 3Y-15.98%
ROICexcg growth 5Y-10.26%
ROICexc growth 3Y-20.69%
ROICexc growth 5Y-11.75%
OM growth 3Y-4.84%
OM growth 5Y1.01%
PM growth 3Y-10.74%
PM growth 5Y-1.82%
GM growth 3Y-0.75%
GM growth 5Y-0.04%
F-Score7
Asset Turnover1.51
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.28 | ||
| Debt/FCF | 2.7 | ||
| Debt/EBITDA | 0.4 | ||
| Cap/Depr | 97.13% | ||
| Cap/Sales | 2.36% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 28.97% | ||
| Profit Quality | 34.7% | ||
| Current Ratio | 2.06 | ||
| Quick Ratio | 1.75 | ||
| Altman-Z | 8.03 |
F-Score7
WACC7.84%
ROIC/WACC3.35
Cap/Depr(3y)763.09%
Cap/Depr(5y)544.05%
Cap/Sales(3y)14.97%
Cap/Sales(5y)11.04%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)20.2%
EPS 3Y6.71%
EPS 5Y14.63%
EPS Q2Q%3.36%
EPS Next Y13.36%
EPS Next 2Y15.1%
EPS Next 3Y14.27%
EPS Next 5YN/A
Revenue 1Y (TTM)15.06%
Revenue growth 3Y19.25%
Revenue growth 5Y16.59%
Sales Q2Q%10.35%
Revenue Next Year14.66%
Revenue Next 2Y13.77%
Revenue Next 3Y12.23%
Revenue Next 5YN/A
EBIT growth 1Y14.83%
EBIT growth 3Y13.47%
EBIT growth 5Y17.77%
EBIT Next Year24.88%
EBIT Next 3Y16.72%
EBIT Next 5Y9.17%
FCF growth 1Y144.25%
FCF growth 3Y1.75%
FCF growth 5Y17.94%
OCF growth 1Y38.33%
OCF growth 3Y0.14%
OCF growth 5Y11.34%